Skip to main navigation Skip to search Skip to main content

Differential anthracycline sensitivity in two related human colon carcinoma cell lines expressing similar levels of P-glycoprotein

  • Alejandra L. Boquete
  • , Laura Vargas Roig
  • , Gustavo A. López
  • , Rajiv Gude
  • , M. Mercedes Binda
  • , Alejandro D. González
  • , Daniel R. Ciocca
  • , R. Daniel Bonfil

Research output: Contribution to journal › Article › peer-review

Abstract

Chemosensitivity of the human colon carcinoma HCT-15 cell line to 4′-epidoxorubicin proved to be 100-fold higher than that of its variant HCT-15 EDR. Confocal scanning microscopy showed significant less drug accumulation in HCT-15 EDR. A 2-fold increase in hsp27 expression was found in HCT-15 EDR, with no alteration in hsp70. The expression of the drug exporter Pgp was similar in both cell lines, despite the lower drug accumulation shown by HCT-15 EDR in respect to HCT-15. Other molecules implicated in the acquisition of enhanced chemoresistance or a more active Pgp variant present in HCT-15 EDR, could explain the phenomenon.

Original languageEnglish
Pages (from-to)111-116
Number of pages6
JournalCancer Letters
Volume165
Issue number1
DOIs
StatePublished - Apr 10 2001
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • 4′-Epidoxorubicin
  • Anthracyclines
  • Colon carcinoma
  • Heat shock proteins
  • Multidrug resistance
  • P-glycoprotein

Fingerprint

Dive into the research topics of 'Differential anthracycline sensitivity in two related human colon carcinoma cell lines expressing similar levels of P-glycoprotein'. Together they form a unique fingerprint.

Cite this